Edition:
United Kingdom

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

24.13USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$24.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
153,396
52-wk High
$30.80
52-wk Low
$20.47

Chart for

About

NxStage Medical, Inc. is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate... (more)

Overall

Beta: -0.05
Market Cap(Mil.): $1,827.08
Shares Outstanding(Mil.): 66.01
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.60
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Alpine Associates Management Reports 6.09 Pct Passive Stake In NxStage Medical

* ALPINE ASSOCIATES MANAGEMENT INC REPORTS A 6.09 PERCENT PASSIVE STAKE IN NXSTAGE MEDICAL, INC AS OF DECEMBER 31, 2017 - SEC FILING Source text:(http://bit.ly/2nN0Xi2) Further company coverage:

08 Feb 2018

BRIEF-NXSTAGE SAYS STOCKHOLDER APPROVE MERGER WITH FRESENIUS MEDICAL CARE

* NXSTAGE ANNOUNCES STOCKHOLDER APPROVAL OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE

27 Oct 2017

BRIEF-NxStage Medical announces FDA clearance for solo home hemodialysis using NxStage system one

* NxStage Medical announces FDA clearance for solo home hemodialysis using NxStage® system one™

28 Aug 2017

Competitors

Earnings vs. Estimates